BOIRON SA (BOI.PA) Stock Fundamental Analysis
EPA:BOI - Euronext Paris - Matif - FR0000061129 - Common Stock - Currency: EUR
Overall BOI gets a fundamental rating of 5 out of 10. We evaluated BOI against 51 industry peers in the Pharmaceuticals industry. BOI has a great financial health rating, but its profitability evaluates not so good. BOI is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year BOI was profitable.
BOI had a positive operating cash flow in the past year.
Each year in the past 5 years BOI has been profitable.
Each year in the past 5 years BOI had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.97%, BOI is doing worse than 62.75% of the companies in the same industry.
BOI's Return On Equity of 3.00% is on the low side compared to the rest of the industry. BOI is outperformed by 62.75% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.54%, BOI is doing worse than 62.75% of the companies in the same industry.
BOI had an Average Return On Invested Capital over the past 3 years of 5.61%. This is significantly below the industry average of 15.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROIC | 2.54% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
1.3 Margins
The Profit Margin of BOI (2.33%) is comparable to the rest of the industry.
BOI's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 3.23%, BOI is doing worse than 60.78% of the companies in the same industry.
BOI's Operating Margin has declined in the last couple of years.
The Gross Margin of BOI (73.58%) is better than 64.71% of its industry peers.
BOI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% |
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOI is destroying value.
Compared to 1 year ago, BOI has about the same amount of shares outstanding.
BOI has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BOI is higher compared to a year ago.
2.2 Solvency
BOI has an Altman-Z score of 3.16. This indicates that BOI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BOI (3.16) is comparable to the rest of the industry.
BOI has a debt to FCF ratio of 0.63. This is a very positive value and a sign of high solvency as it would only need 0.63 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.63, BOI belongs to the top of the industry, outperforming 94.12% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that BOI is not too dependend on debt financing.
BOI has a better Debt to Equity ratio (0.03) than 86.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Altman-Z | 3.16 |
ROIC/WACC0.33
WACC7.8%
2.3 Liquidity
A Current Ratio of 2.51 indicates that BOI has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.51, BOI belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
BOI has a Quick Ratio of 1.61. This is a normal value and indicates that BOI is financially healthy and should not expect problems in meeting its short term obligations.
BOI has a Quick ratio of 1.61. This is amongst the best in the industry. BOI outperforms 84.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
BOI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.36%.
The earnings per share for BOI have been decreasing by -22.40% on average. This is quite bad
Looking at the last year, BOI shows a decrease in Revenue. The Revenue has decreased by -1.15% in the last year.
BOI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.63% yearly.
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
3.2 Future
The Earnings Per Share is expected to grow by 2.73% on average over the next years.
The Revenue is expected to grow by 5.54% on average over the next years.
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 32.46 indicates a quite expensive valuation of BOI.
Compared to the rest of the industry, the Price/Earnings ratio of BOI is on the same level as its industry peers.
When comparing the Price/Earnings ratio of BOI to the average of the S&P500 Index (27.03), we can say BOI is valued slightly more expensively.
BOI is valuated reasonably with a Price/Forward Earnings ratio of 9.12.
76.47% of the companies in the same industry are more expensive than BOI, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 36.28. BOI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.46 | ||
| Fwd PE | 9.12 |
4.2 Price Multiples
96.08% of the companies in the same industry are more expensive than BOI, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BOI indicates a somewhat cheap valuation: BOI is cheaper than 70.59% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.69 | ||
| EV/EBITDA | 5.31 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.87
PEG (5Y)N/A
EPS Next 2Y2.73%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.71%, BOI is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.14, BOI pays a better dividend. On top of this BOI pays more dividend than 92.16% of the companies listed in the same industry.
BOI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.71% |
5.2 History
The dividend of BOI decreases each year by -1.41%.
Dividend Growth(5Y)-1.41%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
206.77% of the earnings are spent on dividend by BOI. This is not a sustainable payout ratio.
DP206.77%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPA:BOI (8/6/2025, 5:29:30 PM)
21.1
-0.15 (-0.71%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners5.63%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap370.31M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.71% |
Yearly Dividend1.35
Dividend Growth(5Y)-1.41%
DP206.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.46 | ||
| Fwd PE | 9.12 | ||
| P/S | 0.76 | ||
| P/FCF | 15.69 | ||
| P/OCF | 9.37 | ||
| P/B | 0.98 | ||
| P/tB | 1.43 | ||
| EV/EBITDA | 5.31 |
EPS(TTM)0.65
EY3.08%
EPS(NY)2.31
Fwd EY10.96%
FCF(TTM)1.34
FCFY6.37%
OCF(TTM)2.25
OCFY10.68%
SpS27.78
BVpS21.55
TBVpS14.77
PEG (NY)5.87
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.97% | ||
| ROE | 3% | ||
| ROCE | 3.39% | ||
| ROIC | 2.54% | ||
| ROICexc | 3.01% | ||
| ROICexgc | 4.32% | ||
| OM | 3.23% | ||
| PM (TTM) | 2.33% | ||
| GM | 73.58% | ||
| FCFM | 4.84% |
ROA(3y)4.57%
ROA(5y)4.15%
ROE(3y)6.7%
ROE(5y)6.13%
ROIC(3y)5.61%
ROIC(5y)5.46%
ROICexc(3y)8.01%
ROICexc(5y)8.34%
ROICexgc(3y)11.86%
ROICexgc(5y)12.41%
ROCE(3y)7.49%
ROCE(5y)7.29%
ROICexcg growth 3Y-33.41%
ROICexcg growth 5Y-24.37%
ROICexc growth 3Y-32.4%
ROICexc growth 5Y-24.82%
OM growth 3Y-32.06%
OM growth 5Y-23.58%
PM growth 3Y-28.17%
PM growth 5Y-20.44%
GM growth 3Y0.74%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | 0.63 | ||
| Debt/EBITDA | 0.18 | ||
| Cap/Depr | 37.59% | ||
| Cap/Sales | 3.27% | ||
| Interest Coverage | 14.49 | ||
| Cash Conversion | 68.03% | ||
| Profit Quality | 208.21% | ||
| Current Ratio | 2.51 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z | 3.16 |
F-Score7
WACC7.8%
ROIC/WACC0.33
Cap/Depr(3y)71.98%
Cap/Depr(5y)71.7%
Cap/Sales(3y)3.47%
Cap/Sales(5y)3.78%
Profit Quality(3y)124.88%
Profit Quality(5y)120.26%
High Growth Momentum
Growth
EPS 1Y (TTM)-68.36%
EPS 3Y-26.29%
EPS 5Y-22.4%
EPS Q2Q%-60.69%
EPS Next Y5.53%
EPS Next 2Y2.73%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.15%
Revenue growth 3Y2.32%
Revenue growth 5Y-2.63%
Sales Q2Q%2.31%
Revenue Next Year2.95%
Revenue Next 2Y1.47%
Revenue Next 3Y8.32%
Revenue Next 5Y5.54%
EBIT growth 1Y-62.79%
EBIT growth 3Y-30.48%
EBIT growth 5Y-25.59%
EBIT Next Year86.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14.06%
FCF growth 3Y22.31%
FCF growth 5Y12.1%
OCF growth 1Y-13.1%
OCF growth 3Y5.87%
OCF growth 5Y-4.91%